stockrowDianthus Therapeutics, Inc. (DNTH) vs Travere Therapeutics, Inc. (TVTX)
- Dianthus Therapeutics, Inc. DNTH 86.43 +4.12%
- Travere Therapeutics, Inc. TVTX 49.45 +1.19%
Dianthus Therapeutics, Inc. and Travere Therapeutics, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Travere Therapeutics, Inc. are of similar size ($4.7B and $4.6B). Travere Therapeutics, Inc. grew revenue faster over the last twelve months: 49.4% against −11.7%. Travere Therapeutics, Inc. has the higher net margin (−18.7% vs −7,436.5%) and the lower return on invested capital (−54.1% vs −36.6%). Across the 17 metrics below, Travere Therapeutics, Inc. leads on 10 and Dianthus Therapeutics, Inc. on 7.
Valuation
Profitability
| Metric | DNTH | TVTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 98.53% | 68.51% |
| Operating margin | (8,683.89%) | (20.51%) | 0.00% |
| Net margin | (7,436.50%) | (18.66%) | 0.00% |
| Free cash flow margin | (6,469.87%) | 13.11% | 0.00% |
| Return on equity | (22.61%) | (252.75%) | (51.96%) |
| Return on assets | (21.81%) | (17.52%) | (46.06%) |
| Return on invested capital | (36.55%) | (54.08%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack